RHS Financial’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$710K Sell
12,159
-620
-5% -$34.6K 0.24% 82
2026
Q2
$695K Buy
12,779
+6
+0% +$292 0.28% 72
2026
Q1
$548K Buy
12,773
+154
+1% +$6.62K 0.26% 71
2025
Q4
$553K Buy
12,619
+293
+2% +$12.1K 0.27% 64
2025
Q3
$509K Buy
12,326
+29
+0.2% +$1.17K 0.26% 68
2025
Q2
$542K Buy
12,297
+519
+4% +$20.7K 0.31% 61
2025
Q1
$435K Buy
+11,778
New +$420K 0.24% 77

Other funds holding EXEL

RHS Financial's EXEL Position: Q3 2026 in Review

RHS Financial reduced its Exelixis (EXEL) stake by 4.9% in Q3 2026, selling an estimated $34.6K and leaving 12,159 shares worth $710K. The position accounts for 0.24% of the portfolio, ranked #82.

RHS Financial first reported a position in EXEL in Q1 2025 and has held it in 7 quarters since. 352 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • RHS Financial held 12,159 shares of Exelixis worth $710K as of Q3 2026.
  • RHS Financial sold 620 Exelixis shares in Q3 2026, an estimated $34.6K.
  • Exelixis made up 0.24% of RHS Financial's portfolio in Q3 2026, its #82 holding.
  • RHS Financial first reported a position in Exelixis in Q1 2025 and has held it in 7 quarters since.
  • 352 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on RHS Financial's 13F filing for Q3 2026, filed 13 Oct 2026.